Encapsulation of Nucleic Acids and Opportunities for Cancer Treatment (original) (raw)
C. V. A. Wynter. The dialectics of cancer: a theory of the initiation and development of cancer through errors in siRNA. Med. Hypotheses66:612–635 (2006). ArticlePubMedCAS Google Scholar
P. T. Reiger. The biology of cancer genetics. Sem. Oncol. Nurs.20:145–154 (2004). Article Google Scholar
R. K. Jain. Transport of molecules, particles and cells in solid tumors. Annu. Rev. Biomed. Eng.1:241–263 (1999). ArticlePubMedCAS Google Scholar
R. K. Jain. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J. Control. Release74:7–25 (2001). ArticlePubMedCAS Google Scholar
R. K. Jain. Delivery of molecular and cellular medicine to solid tumors. Adv. Drug Deliv. Rev.46:149–168 (2001). ArticlePubMedCAS Google Scholar
C. Pozrikidis and D. A. Farrow. A model of fluid flow in solid tumors. Ann. Biomed. Eng. 31:181–194 (2003). ArticlePubMedCAS Google Scholar
M. J. Hawkins, J. R. Lane, L. Harris, P. J. Williams, V. Trieu, P. Soon-Shiong, and N. Desai. Comparative pharmacokinetic (pk) study of a cremophor-free, protein stabilized, nanoparticle formulation (abi-007) and a cremophor-based formulation of paclitaxel (p) in patients with advanced solid tumors. Eur. J. Cancer Suppl. 2:164 (2004). Article Google Scholar
Z. Xu, W. Gu, J. Huang, H. Sui, Z. Zhou, Y. Yang, Z. Yan, and Y. Li. In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. Int. J. Pharm. 288:361–368 (2005). ArticlePubMedCAS Google Scholar
H. Miura, H. Onishi, M. Sasatsu, and Y. Machida. Antitumor characteristics of methoxypolyethylene glycol-poly(-lactic acid) nanoparticles containing camptothecin. J. Control. Release97:101–113 (2004). ArticlePubMedCAS Google Scholar
J. Hyung Park, S. Kwon, M. Lee, H. Chung, J.-H. Kim, Y.-S. Kim, R.-W. Park, I.-S. Kim, S. Bong Seo, I. C. Kwon, and S. Young Jeong. Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity. Biomaterials27:119–126 (2006). ArticlePubMedCAS Google Scholar
S. A. Rosenberg, P. M. Aebersold, K. Cornetta, A. Kasid, R. A. Morgan, R. Moen, E. M. Karson, M. T. Lotze, J. C. Yang, S. L. Topalian, M. H. Merino, K. Culver, A. D. Miller, M. D. Blaese, and W. F. Anderson. Gene transfer into humans-immunotherapy of patients with advanced melanoma, using tumor infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 323:570–578 (1990). ArticlePubMedCAS Google Scholar
T. Niidomeand and L. Huang. Gene therapy progress and prospects: non-viral vectors. Gene Ther. Wkly. 9:1647–1652 (2002). ArticleCAS Google Scholar
S. E. Raper, N. Chirmule, F. S. Lee, N. A. Wivel, A. Bagg, G. P. Gao, J. M. Wilson, and M. L. Batshaw. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Molec. Genet. Metab. 80:148–158 (2003). ArticleCASPubMed Google Scholar
S. Hacein-Bey-Abina, C. von Kalle, M. Schmidt, F. Le Deist, N. Wulffraat, E. McIntyre, I. Radford, J. L. Villeval, C. C. Fraser, M. Cavazzana-Calvo, and A. Fischer. A serious adverse event after successful gene therapy for x-linked severe combined immunodeficiency. N. Engl. J. Med. 348:255–256 (2003). ArticlePubMed Google Scholar
Y. Kaneda and Y. Tabata. Non-viral vectors for cancer therapy. Cancer Sci.97:348–354 (2006). ArticlePubMedCAS Google Scholar
G. Kaul and M. Amiji. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. Pharm. Res.22:951–961 (2005). ArticlePubMedCAS Google Scholar
D. W. Pack, A. S. Hoffman, S. Pun, and P. S. Stayton. Design and development of polymers for gene delivery. Nat. Rev., Drug Discov. 4:581–593 (2005). ArticleCAS Google Scholar
R. A. Jain. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials21:2475–2490 (2000). ArticlePubMedCAS Google Scholar
D. T. Birnbaum, J. D. Kosmala, and L. Brannon-Peppas. Optimization of preparation techniques for poly(lactic acid-co-glycolic acid) nanoparticles. J. Nanopart. Res. 2:173–181 (2000). ArticleCAS Google Scholar
F. Fawaz, F. Bonini, M. Guyot, A.-M. Lagueny, H. Fessi, and J.-P. Devissaguet. Influence of poly(dl-lactide) nanocapsules on the biliary clearance and enterohepatic circulation of indomethacin in the rabbit. Pharm. Res.10:750–756 (1993). ArticlePubMedCAS Google Scholar
P. D. Scholes, A. G. A. Coombes, L. Illum, S. S. Davis, M. Vert, and M. C. Davies. The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery. J. Control. Release25:145–153 (1993). ArticleCAS Google Scholar
H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release65:271–284 (2000). ArticlePubMedCAS Google Scholar
B. Stella, S. Arpicco, M. T. Peracchia, D. Desmaele, J. Hoebeke, M. Renoir, J. D’Angelo, L. Cattel, and P. Couvreur. Design of folic acid-conjugated nanoparticles for drug targeting. J. Pharm. Sci. 89:1452–1464 (2000). ArticlePubMedCAS Google Scholar
G. Russell-Jones, K. McTavish, J. McEwan, J. Rice, and D. Nowotnik. Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours. J. Inorg. Biochem. 98:1625–1633 (2004). ArticlePubMedCAS Google Scholar
J. Jo, M. Yamamoto, K. Matsumoto, T. Nakamura, and Y. Tabata. Liver targeting of plasmid DNA with a cationized pullulan for tumor suppression. J. Nanosci. Nanotech.6:2853–2859 (2006). ArticleCAS Google Scholar
S. Krasnici, A. Werner, M. Eichhorn, M. Schmitt-Sody, S. Pahernik, B. Sauer, B. Schulze, M. Teifel, U. Michaelis, K. Naujoks, and M. Dellian. Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. Int. J. Cancer105:561–567 (2003). ArticlePubMedCAS Google Scholar
M. C. Woodleand and P. Y. Lu. Nanoparticles deliver rnai therapy. Nanotoday August8:34–41 (2005). Google Scholar
A. V. Harpe, H. Petersen, Y. Li, and T. Kissel. Characterization of commercially available and synthesized polyethylenimines for gene delivery. J. Control. Release69:309–322 (2000). Article Google Scholar
S. Kawakami, S. Fumoto, M. Nishikawa, F. Yamashita, and M. Hashida. In vivo gene delivery to the liver using novel galactosylated cationic liposomes. Pharm. Res.17:306–313 (2000). ArticlePubMedCAS Google Scholar
P. Lemieux, S. V. Vinogradov, C. L. Gebhart, N. Guerin, G. Paradis, H.-K. Nguyen, B. Ochietti, Y. G. Suzdaltseva, E. V. Bartakova, T. K. Bronich, Y. St.-Pierre, V. Y. Alakhov, and A. V. Kabanov. Block and graft copolymers and nanogel copolymer networks for DNA delivery into cell. J. Drug Target. 8:91–105 (2000). PubMedCAS Google Scholar
Y.-B. Lim, S.-O. Han, H.-U. Kong, Y. Lee, J.-S. Park, B. Jeong, and S. W. Kim. Biodegradable polyester, poly(alpha-(4-aminobutyl)-l-glycolic acid), as a non-toxic gene carrier. Pharm. Res. 17:811–816 (2000). ArticlePubMedCAS Google Scholar
E. G. Saravolac, O. Ludkovski, R. Skirrow, M. Ossanlou, Y. P. Zhang, C. Giesbrecht, J. Thompson, S. Thomas, H. Stark, P. R. Cullis, and P. Scherrer. Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity. J. Drug Target.7:423–437 (2000). ArticlePubMedCAS Google Scholar
E. Schacht, V. Toncheva, L. D. Kie, and P. Dubruel. Synthetic polymers as vectors for gene delivery. Polym Prepr (Am Chem Soc, Div Polym Chem)41:1609–1610 (2000). CAS Google Scholar
S. W. Yi, T. Y. Yune, T. W. Kim, H. Chung, Y. W. Choi, I. C. Kwon, E. B. Lee, and S. Y. Joeng. A cationic lipid emulsion/DNA complex as a physically stable and serum-resistant gene delivery system. Pharm. Res.17:314–320 (2000). ArticlePubMedCAS Google Scholar
N. Shi, R. J. Boado, and W. M. Pardridge. Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes. Pharm. Res.18:1091–1095 (2001). ArticlePubMedCAS Google Scholar
P. Dubruel, B. Christiaens, B. Vanloo, K. Bracke, M. Rosseneu, J. Vandekerckhove, and E. Schacht. Physcichemical and biological evaluation of cationic polymethacrylates as vectors for gene delivery. Eur. J. Pharm. Sci.18:211–220 (2003). ArticlePubMedCAS Google Scholar
T. Hao, U. McKeever, and M. L. Hedley. Biological potency of microsphere encapsulated plasmid DNA. J. Control. Release69:249–259 (2000). ArticlePubMedCAS Google Scholar
L. Lunsford, U. McKeever, V. Eckstein, and M. L. Hedley. Tissue distribution and persistence in mice of plasmid DNA encapsulated in a PLGA-based microsphere delivery vehicle. J. Drug Target. 8:39–50 (2000). PubMedCAS Google Scholar
A. M. Tinsley-Bown, R. Fretwell, A. B. Dowsett, S. L. Davis, and G. H. Farrar. Formulation of poly(d,l-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. J. Control. Release66:229–241 (2000). ArticlePubMedCAS Google Scholar
M. Stern, K. Ulrich, D. M. Geddes, and E. W. Alton. Poly (d, l-lactide-co-glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo. Gene Therapy10:1282–1288 (2003). ArticlePubMedCAS Google Scholar
S. R. Little, D. M. Lynn, Q. Ge, D. G. Anderson, S. V. Puram, J. Chen, H. N. Eisen, and R. Langer. Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. Proc. Natl. Acad. Sci. USA.101:9534–9539 (2004). ArticlePubMedCAS Google Scholar
E. Walter, D. Dreher, M. Kok, L. Thiele, S. G. Kiama, P. Gehr, and H. P. Merkle. Hydrophilic poly(dl-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells. J. Control. Release76:149–168 (2001). ArticlePubMedCAS Google Scholar
E. Walter, L. Thiele, and H. P. Merkle. Gene delivery systems to phagocytic antigen-presenting cells. STP Pharma. Sci. 11:45–56 (2001). CAS Google Scholar
E. Walter, K. Moelling, J. Pavlovic, and H. P. Merkle. Microencapsulation of DNA using poly(dl-lactide-co-glycolide): stability issues and release characteristics. J. Control. Release61:361–374 (1999). ArticlePubMedCAS Google Scholar
U. McKeever, S. Barman, T. Hao, P. Chambers, S. Song, L. Lunsford, Y. Hsu, K. Roy, and M. Hedley. Protective immune responses elicited in mice by immunization with formulations of poly(lactide-co-glycolide) microparticles. Vaccine. 20:1524–1531 (2002). ArticlePubMedCAS Google Scholar
S. L. Goh, N. Murthy, M. Xu, and J. M. Frechet. Cross-linked microparticles as carriers for the delivery of plasmid DNA for vaccine development. Bioconjug. Chem. 15:67–74 (2004). ArticleCAS Google Scholar
S. P. Kasturi, K. Sachaphibulkij, and K. Roy. Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines. Biomaterials26:6375–6385 (2005). ArticlePubMedCAS Google Scholar
G. Lambert, E. Fattal, and P. Couvreur. Nanoparticulate systems for the delivery of antisense oligonucleotides. Adv. Drug Deliv. Rev. 47:99–112 (2001). ArticlePubMedCAS Google Scholar
J. M. Benns and S. W. Kim. Tailoring new gene delivery designs for specific targets. J. Drug Target. 8:1–12 (2000). ArticlePubMedCAS Google Scholar
G. Giammona, G. Cavallaro, G. Pitarresi, and E. Pedone. Novel polyaminoacidic copolymers as nonviral gene vectors. Colloid Polym. Sci. 278:69–73 (2000). ArticleCAS Google Scholar
S. Ohashi, T. Kubo, T. Ikeda, Y. Arai, K. Takahashi, Y. Hirasawa, M. Takigawa, E. Satoh, J. Imanishi, and O. Mazda. Cationic polymer-mediated genetic transduction into cultured human chondrosarcoma-derived hcs-2/8 cells. J. Orthop. Sci. 6:75–81 (2001). ArticlePubMedCAS Google Scholar
W. Suh, S.-O. Han, L. Yu, and S. W. Kim. An angiogenic, endothelial-cell-targeted polymeric gene carrier. Mol. Ther. 6:664–672 (2002). ArticlePubMedCAS Google Scholar
J. Panyam and V. Labhasetwar. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55:329–347 (2003). ArticlePubMedCAS Google Scholar
S.-O. Han, R. I. Mahato, Y. K. Sung, and S. W. Kim. Development of biomaterials for gene therapy. Mol. Ther. 2:302–317 (2000). ArticlePubMedCAS Google Scholar
T. Merdan, J. Kopecek, and T. Kissel. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv. Drug Deliv. Rev. 54:715–758 (2002). ArticlePubMedCAS Google Scholar
A. Vila, A. Sanchez, C. Perez, and M. J. Alonso. PLA-PAG nanospheres: New carriers for transmucosal delivery of proteins and plasmid DNA. Polym. Adv. Technol. 13:851–858 (2002). ArticleCAS Google Scholar
G. G. d. Barrio, F. J. Novo, and J. M. Irache. Loading of plasmid DNA into PLGA microparticles using TROMS (total recirculation one-machine system): evaluation of its integrity and controlled release properties. J. Control. Release86:123–130 (2003). ArticlePubMed Google Scholar
S. Rhaese, H. v. Briesen, H. Rubsamen-Waigmann, J. Kreuter, and K. Langer. Human serum albumin-polyethylenimine nanoparticles for gene delivery. J. Control. Release92:199–208 (2003). ArticlePubMedCAS Google Scholar
S. Prabha and V. Labhasetwar. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression. Pharm. Res. 21:354–364 (2004). ArticlePubMedCAS Google Scholar
S. Hirosue, B. G. Müller, R. C. Mulligan, and R. Langer. Plasmid DNA encapsulation and release from solvent diffusion nanospheres. J. Control. Release70:231–242 (2001). ArticlePubMedCAS Google Scholar
Y. Liu and X. Deng. Influences of preparation conditions on particle size and DNA-loading efficiency for poly(dl-lactic acid-polyethylene glycol) microspheres entrapping free DNA. J. Control. Release83:147–155 (2002). ArticlePubMedCAS Google Scholar
C. Perez, A. Sanchez, D. Putman, D. Ting, R. Langer, and M. J. Alonso. Poly(lactic acid)-poly)ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J. Control. Release75:211–224 (2001). ArticlePubMedCAS Google Scholar
M. Sandor, S. Mehta, J. Harris, C. Thanos, P. Weston, J. Marshall, and E. Mathiowitz. Transfection of hek cells via DNA-loaded PLGA and p(FASA) nanospheres. J. Drug Target. 10:497–506 (2002). ArticlePubMedCAS Google Scholar
S. Ando, D. Putnam, D. W. Pack, and R. Langer. Plga microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J. Pharm. Sci. 88:126–130 (1999). ArticlePubMedCAS Google Scholar
J. H. Jeong, S. W. Kim, and T. G. Park. Biodegradable triblock copolymer of PLGA-PEG-PLGA enhances gene transfection efficiency. Pharm. Res. 21:50–54 (2004). ArticlePubMedCAS Google Scholar
S. Mansouri, P. Lavigne, K. Corsi, M. Benderdour, E. Beaumont, and J. C. Fernandes. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur. J. Pharm. Biopharm. 57:1–8 (2004). ArticlePubMedCAS Google Scholar
H. Mao, K. Roy, V. Troung-Le, K. Janes, K. Lin, Y. Wang, J. August, and K. Leong. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Control. Release70:399–421 (2001). ArticlePubMedCAS Google Scholar
K. Roy, H. Mao, S. Huang, and K. Leong. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 5:387–391 (1999). ArticlePubMedCAS Google Scholar
A. Bozkir and I. M. Saka. Chitosan nanoparticles for plasmid DNA delivery: effect if chitosan molecular structure on formulation and release characteristics. Drug Deliv. 11:107–112 (2004). ArticlePubMedCAS Google Scholar
M. N. V. R. Kumar, U. Bakowsky, and C. M. Lehr. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials25:1771–1777 (2004). ArticleCAS Google Scholar
U. Galderisi, A. Cascino, and A. Giordano. Antisense oligonucleotides as therapeutic agents. J. Cell Physiol. 181:251–257 (1999). ArticlePubMedCAS Google Scholar
C. Chavany, Y. Connell, and L. Neckers. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers. Mol. Pharmacol. 48:736–746 (1995). Google Scholar
B. P. Monia, J. F. Johnston, T. Geiger, M. Muller, and D. Fabbro. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against c-raf kinase. Nat. Med. 2:668–675 (1996). ArticlePubMedCAS Google Scholar
M. D. deSmet, C. J. Meenken, and G. J. v. d. Horn. Fomivirsen—a phosphorothioate oligonucleotide for the treatment of cmv retinitis. Ocul. Immunol. Inflamm. 7:189–198 (1999). ArticleCAS Google Scholar
M. Butler and K. Stecker. Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues. Lab. Invest. 77:379–388 (1997). PubMedCAS Google Scholar
R. Z. Yu and J. Q. Su. Prediction of clinical responses in a simulated phase III trial of Crohn’s patients administered the antisense phosphorothioate oligonucleotide ISIS 2302: comparison of proposed dosing regimens. Antisense Nucleic Acid Drug Dev. 13:57–66 (2003). ArticlePubMedCAS Google Scholar
S. M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature411:494–498 (2001). ArticlePubMedCAS Google Scholar
R. L. Juliano, S. Alahari, H. Yoo, R. Kole, and M. Cho. Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides. Pharm. Res. 16:494–502 (1999). ArticlePubMedCAS Google Scholar
C. J. Marcus-Sekura, A. M. Woerner, K. Shinozuka, G. Zon, and G. V. Quinnan. Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotides analogues having alkyl phosphotriester, methylphosphonate and phosphorothioate linkages. Nucleic Acids Res. 15:5749–5763 (1987). ArticlePubMedCAS Google Scholar
A. C. Kilic, Y. Capan, I. Vural, R. N. Gursoy, T. Dalkara, A. Cuine, and A. A. Hincal. Preparation and characterization of PLGA nanospheres for the targeted delivery of nr2b-specific antisense oligonucleotides to the nmda receptors in the brain. J. Microencapsul22:633–641 (2005). ArticlePubMedCAS Google Scholar
G. Lambert, J. R. Bertrand, E. Fattal, F. Subra, H. Pinto-Alphandary, C. Malvy, C. Auclair, and P. Couvreur. Ews fli-1 antisense nanocapsules inhibits Ewing sarcoma-related tumor in mice. Biochem. Biophys. Res. Commun. 279:401–406 (2000). ArticlePubMedCAS Google Scholar
A. J. Hollins, M. Benboubetra, Y. Omidi, B. H. Zinselmeyer, A. G. Schatzlein, I. F. U. IF, and S. Akhtar. Evaluation of generation 2 and 3 poly(propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor. Pharm. Res. 21:458–466 (2004). ArticlePubMedCAS Google Scholar
L. M. Santhakumaran, T. Thomas, and T. J. Thomas. Enhanced cellular uptake of a triplex-forming oligonucleotide by nanoparticle formation in the presence of polypropylenimine dendrimers. Nucleic Acids Res. 32:2102–2112 (2004). ArticlePubMedCAS Google Scholar
D. Lochmann, J. Weyermann, C. Georgens, R. Prassl, and A. Zimmer. Albumin-protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: physicochemical characterization. Eur. J. Pharm. Biopharm. 59:419–429 (2005). ArticlePubMedCAS Google Scholar
J. Weyermann, D. Lochmann, C. Georgens, and A. Zimmer. Albumin-protamine-oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect. Eur. J. Pharm. Biopharm. 59:431–438 (2005). ArticlePubMedCAS Google Scholar
J. H. Seong, K. M. Lee, S. T. Kim, S. E. Jin, and C. K. Kim. Polyethylenimine-based antisense oligodeoxynucleotides of il-4 suppress the production of il-4 in a murine model of airway inflammation. J. Gene Med. 8:314–323 (2006). ArticlePubMedCAS Google Scholar
S. Gao, J. Chen, L. Dong, Z. Ding, Y. H. Yang, and J. Zhang. Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector. Eur. J. Pharm. Biopharm. 60:327–334 (2005). ArticlePubMedCAS Google Scholar
S. P. Kasturi, H. Qin, K. S. Thomson, S. El-Bereir, S. C. Cha, S. Neelapu, L. W. Kwak, and K. Roy. Prophylactic anti-tumor effects in a b cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles. J. Control. Release113:261–270 (2006). ArticleCAS Google Scholar
A. Maheshwari, R. I. Mahato, J. McGregor, S. Han, W. E. Samlowski, J. S. Park, and S. W. Kim. Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment. Mol. Ther. 2:121–130 (2000). ArticlePubMedCAS Google Scholar
R. M. Schiffelers, A. Ansari, J. Xu, Q. Zhou, Q. Tang, G. Storm, G. Molema, P. Y. Lu, P. V. Scaria, and M. C. Woodle. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. 32:e149 (2004). ArticlePubMed Google Scholar